The head of the Permanante Federation says innovation is critical to improving U.S. health care.
In an interview with Kewen Jin, the serial entrepreneurs discusses the rapid growth of China's health care industry and the idea of "innovation by subtraction."
A talk with a Stanford dermatologist and entrepreneur who cofounded an internet alternative to the doctors’ office.
Business and government leaders, entrepreneurs, academics, and students gather this week at the Stanford Graduate School of Business for the 2012 Healthcare Innovation Summit to examine the forces shaping the future of health care and discuss practical solutions to some of our toughest health care problems. In an online forum, Stefanos Zenios responds to reader questions on innovation in the field.
Using brain imaging and a video game, researchers teach girls at risk of depression how to train their brains away from negative situations.
The head of the Permanante Federation says innovation is critical to improving U.S. health care.
In an interview with Kewen Jin, the serial entrepreneurs discusses the rapid growth of China's health care industry and the idea of "innovation by subtraction."
A talk with a Stanford dermatologist and entrepreneur who cofounded an internet alternative to the doctors’ office.
Business and government leaders, entrepreneurs, academics, and students gather this week at the Stanford Graduate School of Business for the 2012 Healthcare Innovation Summit to examine the forces shaping the future of health care and discuss practical solutions to some of our toughest health care problems. In an online forum, Stefanos Zenios responds to reader questions on innovation in the field.
Using brain imaging and a video game, researchers teach girls at risk of depression how to train their brains away from negative situations.
Grassroot Soccer uses the world’s most popular sport to educate kids in sub-Saharan Africa about HIV and its prevention. —By Corey Binns
Public nursing homes outshine nonprofits and for-profits.
When the Salk polio vaccine proved to be effective in 1955, the National Foundation for Infantile Paralysis had to choose whether to close up shop or to pursue a new agenda. The foundation first broadened its mission, but lost donations, volunteers, and public support. After honing its mission to birth defects, however, it recovered. Here’s how the organization that eventually became the March of Dimes planned—and survived—its transitions. —By Georgette Baghdady & Joanne M. Maddock
Toxic environments knock impoverished kids’ systems out of kilter.
The Population Media Center mixes science with soap operas to protect public health. —By Corey Binns
Social media is helping people self-assemble for social action.
A look at how community advisory committees are faring in the health field.
Amidst much debate and acrimony, Congress has at last passed the Affordable Care Act -- the new health law. The law makes health coverage available to those denied health insurance by private insurance companies because of a pre-existing condition. In this panel discussion at Stanford, medical and public health experts consider what's strong and weak about the new measure, and how it will change our health care system.
You are missing some Flash content that should appear here! Perhaps your browser cannot display it, or maybe it did not initialize correctly.
You are missing some Flash content that should appear here! Perhaps your browser cannot display it, or maybe it did not initialize correctly.
You are missing some Flash content that should appear here! Perhaps your browser cannot display it, or maybe it did not initialize correctly.
You are missing some Flash content that should appear here! Perhaps your browser cannot display it, or maybe it did not initialize correctly.
The abuse of the synthetic drug known as methamphetamine has become a top crime problem in the United States, and now a global epidemic. In this audio lecture, part of the Stanford Social Innovation Review's conference on evaluation, IT leader and philanthropist Thomas Siebel discusses the nature of meth addiction as well as the efforts of the Meth Project, a large-scale prevention program aimed at reducing first-time meth use through public service messaging, public policy, and community outreach.
You are missing some Flash content that should appear here! Perhaps your browser cannot display it, or maybe it did not initialize correctly.
"You are more likely to have your plan of care influenced by your zipcode than the stage of your disease," says Richard Migliori. "30% of our expenditures could be reduced if we have a normalization of this variation."
Problem: the only remedy for morbid obesity is invasive surgery. Innovation: an oral device that reduces obesity without an incision.
"Innovation isn't about a point in time, it's about creating sustainable change over time," says Paul Wallace.
Government representatives and venture capitalists came together to hear Stanford student teams speak about the barriers that routinely prevent healthcare innovations from getting to market.
Smoking has been considered a leading cause of preventable death in the United States and on the global level. This audio lecture from the the 2011 Global Health Care Series features Stanford Professor Robert Proctor, the first historian to testify in the federal courts as an expert witness against the tobacco industry. He explores the scale of the global tobacco epidemic and the social forces that have advanced it as a popular consumer product.
You are missing some Flash content that should appear here! Perhaps your browser cannot display it, or maybe it did not initialize correctly.
Investors provide insight on early-stage startup fundraising and advice to those interested in starting their own ventures in healthcare.
How did the global tobacco epidemic start? And what can we learn from it?
What can pharmaceutical companies do to contribute to global health?
Why has American obesity increased so dramatically in the past four decades? How can this trend be reversed?
Genzyme Tissue Repair had just received favorable phase I clinical trial results. Should the company go ahead with studies that would involve subjects in the placebo group having to undergo surgery but not receive the experimental transplants?
In 1999, Geron Corporation was at the center of the debate about human embryo research. The case details the controversy surrounding Geron’s stem cell research and the role the Ethics Advisory Board played in shaping the company's response.
Zeneca launched an ad campaign to promote a drug for use in reducing the risk of breast cancer. The case details the company’s development of the drug and its marketing efforts.
Two companies are competing to develop a genetic test for breast and ovarian cancer susceptibility. They must grapple with concerns about the ethics involved.
This note provides an overview of the role of employers, carriers, and consumers in the U.S. private health insurance market. It covers the history of employer-based coverage, employer decisions on health insurance, insurance pricing, and other topics.
Adiana’s new female sterilization catheter had proven to be successful in preliminary trials in Mexico. The company president had to make decisions about subject consent and Adiana’s responsibility to participants in further trials.
Merck was grappling with how to distribute an HIV drug in limited supply. The decision team had chosen to manage distribution from one source, and was meeting to review the progress and success of its plan.
Interplast was the first international humanitarian organization to send U.S. doctors overseas to provide free reconstructive surgery in developing countries. This case and its campanion videocase chronicle the debates that arose as the organization began to shift its focus from direct service to education.
In Africa, GlaxoSmithKline had to determine how to address the AIDS crisis while maintaining business viability. The case details the interventions of Stanford business alumnus Jean-Pierre Garnier to set the public tone for the company and its worldwide operations.
These notes discuss the AIDS epidemic including history, treatment, drug pricing, and economics.
In 2006, AARP was one of the largest, most well-known nonprofits in the United States. However, the organization faced numerous public relations and strategic challenges.
In 2006, all major U.S. dialysis providers faced ever-diminishing margins and struggled to understand what lay ahead. Change was imminent as Medicare and Medicaid altered the reimbursement landscape, and as private payers became more restrictive.
By early 2006, PacifiCare's African American Health Solution had made significant headway in its two primary markets of Dallas and Los Angeles. Now the health insurance program had to define its purpose more clearly in the face of growing competition for the business of African Americans.
The Canary Fund supports the development of methods for early cancer detection. This first case describes the choice to sponsor a high-profile racing event to raise funding and awareness.
In the mid-2000s, drug eluting stents had been shown to significantly reduce restenosis rates and promised to be one of the most dynamic and complex segments of the medical device industry: explosive growth, product recalls, and intellectual property litigation, but also inter-industry collaboration.
The U.S. health system has been described as the most competitive, heterogeneous, inefficient, fragmented, and advanced system of care in the world. Professor Alan Garber considers how that system compares to those of other wealthy countries, and concludes that it is indeed less efficient and productive, and in need of cost-controlling reforms.
Pauline Vaillancourt Rosenau and Christiaan Lako analyze the 2006 Dutch health insurance reform effort inspired by the work of Professor Alain Enthoven and based on regulated competition. The researchers draw lessons for the United States from the first two years of the plan's application in the Netherlands.
Does the removal of high-cost individuals from private insurance markets lead to greater coverage for individuals who are not as high cost? John Cogan, Glenn Hubbard, and Daniel Kessler find that the insurance coverage of individuals with a health condition that limited their ability to work increased significantly in states with high versus low rates of disability.
The study surveys a large, national sample of American adults about their willingness to pay for health reform. David Brady and Daniel Kessler find that self-identified Republicans, older Americans, and high-income Americans are less supportive of reform.
Daniel Kessler and David Brady examine the possibilities for health care reform in the 111th Congress. Analyzing the failure of Congress to pass the Clinton health plan in 1993-94, they conclude that the factors that created gridlock in the 103rd Congress are likely to have a similar impact in the present.
The two-quarter Elective Course series provides lectures from a diverse group of faculty that expose students to the practical aspects of technology invention and development. The class features a presentation or discussion from one of the guest speakers or faculty. Students work in small project teams in the Biodesign prototyping lab or bench space, collaborating with the fellows of the program.
The purpose of this class is to provide students with the economic tools and the institutional and legal background to understand how markets for health care products and services work. The class utilizes case studies, lectures, and visits from individuals in the industry.
This course examines health care businesses and how they use technology (primarily biotechnology, medical technology, and information technology) to improve patient outcomes and manage costs. Through case studies, students gain an in-depth understanding of how new technologies get developed and commercialized in health care, and of how the whole health care value chain adapts to new technologies.
This course examines the application of cost-effectiveness and cost-benefit analysis, along with other evaluation techniques, to products and services such as medical care, whose "output" is difficult to measure. It critically reviews studies that apply cost analysis techniques to specific clinical problems.
Vision care is something that is practically taken for granted in the United States, but that’s not the case throughout much of the world. Some 300 million around the globe suffer from correctable vision loss, leading, as Ashanthi Mathai, MBA '04, says, “to people accepting their vision impairment and adjusting their lives around it.” The result? A lower quality of life, restricted job options, and even further economic distress.
Jane Chen's passion for helping others has taken her on an incredible journey from doing social work in China to founding Embrace, a company that sells premature infant incubators.
Caring for aging parents is a challenge many face, yet there is no clear path or pattern for how to manage this stage of life. Karen Routt shares her expertise at the nexus between technology and caring for the elderly.
With a high-tech background, an MBA, and an M.D., Dr. Patty Einarson has a unique perspective on the intersection of technology, business and medicine. She leverages this knowledge by contributing to math/science education in the public schools, encouraging the kids of today to become future innovators.
Mark Cafferty is passionate about empowering individuals to be all they can be. He channels funds to employment and youth service programs.
Abbott’s John Capek discusses health care device regulation, transparency, and the critical relationship between physicians and their patients
The head of the Permanante Federation says innovation is critical to improving U.S. health care.
In an interview with Kewen Jin, the serial entrepreneurs discusses the rapid growth of China's health care industry and the idea of "innovation by subtraction."
A talk with a Stanford dermatologist and entrepreneur who cofounded an internet alternative to the doctors’ office.
Business and government leaders, entrepreneurs, academics, and students gather this week at the Stanford Graduate School of Business for the 2012 Healthcare Innovation Summit to examine the forces shaping the future of health care and discuss practical solutions to some of our toughest health care problems. In an online forum, Stefanos Zenios responds to reader questions on innovation in the field.